Regulatory Affairs for Biomaterials and Medical Devices

Erscheinungsjahr 2014
ISBN: 978-0-85709-542-8
Verlag: Elsevier Science

Buch, Englisch, 202 Seiten, Format (B × H): 156 mm x 236 mm, Gewicht: 440 g

All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Chapters focus on a series of procedures and policies including topics such as commercialization, clinical development, general good practise manufacturing and post market surveillance.

Zielgruppe

This book will be an important resource for regulatory managers within industry and academia, and should be especially helpful for smaller firms which do not employ a full time vigilance professional.

Autoren/Hrsg.

Amato, Stephen F

Ezzell Jr, Robert M

Fachgebiete

• Rechtswissenschaften Recht, Rechtswissenschaft Allgemein Recht mehrerer Jurisdiktionen, Synopsen
• Rechtswissenschaften Öffentliches Recht Medizin- und Gesundheitsrecht Arzneimittelrecht und Medizinprodukterecht, Apothekenrecht, Krankenhausrecht
• Technische Wissenschaften Sonstige Technologien | Angewandte Technik Medizintechnik, Biomedizintechnik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizintechnik, Biomedizintechnik, Medizinische Werkstoffe
• Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizinrecht, Gesundheitsrecht
• Rechtswissenschaften Ausländisches Recht Common Law (UK, USA, Australien u.a.)

Inhaltsverzeichnis

1. Biomaterials and their applications in medicine I. Kulinets, Northeastern University, USA 2. Technical considerations for the commercialization of biomaterials N. Scarborough, NLS Consulting, USA and N. Mukherjee, Covidien, USA 3. Regulatory strategies for biomaterials and medical devices in the USA: Classification, design and risk analysis S. F. Amato, Northeastern University, USA 4. Clinical development and endpoint strategies for biomaterials and medical devices S. F. Amato, Northeastern University, USA 5. The clinical evaluation and approval threshold of biomaterials and medical devices K. G. Stevens, DePuy Synthes Spine, USA 6. Supply chain controls for biomaterials and medical devices in the USA S. F. Amato, Northeastern University, USA 7. Global marketing authorisation of biomaterials and medical devices J. J. Tobin, ChemHaz Solutions, Ireland 8. Good manufacturing practice (GMP) for biomaterials and medical devices in the EU and the USA F. Tarabah, Strategiqual, France 9. Post market surveillance approaches for biomaterials and medical devices in the USA K. Desai, Northeastern University, USA 10. Fundamentals of medical device approval in Asia J. L. Wong, ARPA, Hong Kong and P. Teysseyre, Johnson & Johnson Medical Asia Pacific, Singapore

Über Autor(innen)

Amato, Stephen F
Dr Amato teaches at Northeastern University, is a senior lecturer at Boston College and serves on the board of directors for several organizations, including BioSignostix, the Medical Development Group (MDG) and the Association of Graduate Regulatory Educators (AGRE). His research has been extensively published and he has presented on regulatory affairs across the United States, China and India.